Skip to main content
Published locations for Idelalisib and rituximab produce responses in 97% with CLL
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Idelalisib and rituximab produce responses in 97% with CLL
User login
Username
Password
Reset your password
/content/idelalisib-and-rituximab-produce-responses-97-cll
/oncologypractice/article/59141/leukemia-myelodysplasia-transplantation/idelalisib-and-rituximab
/hematology-oncology/article/59141/leukemia-myelodysplasia-transplantation/idelalisib-and-rituximab